Overview Safety and Tolerability of Intravenous Administration of ICVB-1042 Status: Recruiting Trial end date: 2026-12-01 Target enrollment: Participant gender: Summary Study to evaluate the safety and tolerability of intravenous ICVB-1042 Phase: Phase 1 Details Lead Sponsor: IconOVir Bio